Vaciome Pte.
Latest round
- Series A
Last raised
- Apr 2024
Total raised
- $6.2M
Investors
- 8
About Vaciome Pte.
Based in Singapore, Vaciome Pte. Ltd. dba Peptobiotics operates as a biotech company that offers synthetic biology alternatives to livestock antibiotics. Jonathan Bester is the founder and serves as the CEO of the company as of 2021. The company is funded by EF Venture Capital. The company develops recombinant livestock feed additives as replacements for agricultural antibiotics and hormones. Its solution includes bioactive peptides that maintain their structure in the gut, fighting pathogens and optimizing intestinal health from inside the animal.
Who invested in Vaciome Pte.
8 investors across 1 round
See all investors in Vaciome Pte.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 8, 2024
Amount
$6.2M
Investors
Questions about Vaciome Pte.
Who invested in Vaciome Pte.?
Vaciome Pte. has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vaciome Pte. raised?
Vaciome Pte. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Vaciome Pte. last raise money?
Vaciome Pte.'s most recent round on record is a Series A, in Apr 2024.
What does Vaciome Pte. do?
Based in Singapore, Vaciome Pte.
Where is Vaciome Pte. headquartered?
Vaciome Pte. is headquartered in Singapore.
Which VCs invest in companies like Vaciome Pte.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Vaciome Pte.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Vaciome Pte.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.